The multifaceted haptoglobin in the context of adipose tissue and metabolism

Endocrine Reviews

Volumn 37, Issue 4, 2016, Pages 403-416

  Maffei, Margherita ^a,c   Barone, Ilaria ^b,c   Scabia, Gaia ^c   Santini, Ferruccio ^c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; HAPTOGLOBIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; CHEMOTAXIS; COMORBIDITY; FUTUROLOGY; HUMAN; METABOLIC DISORDER; METABOLISM; MUSCLE FUNCTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; WHITE ADIPOSE TISSUE; BLOOD; INFLAMMATION;

ADIPOSE TISSUE, WHITE; HAPTOGLOBINS; HUMANS; INFLAMMATION; OBESITY;

EID: 85019214437     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2016-1009     Document Type: Review

References (115)

1. Polonovski M, Jayle MF. Existence dans le plasma sanguin d'une substance activant l'action peroxydasique, l'haptoglobine. C R Soc Biol. 1938;129:457-460
2. Kushner I, Gewurz H, Benson MD. C-reactive protein and the acute-phase response. J Lab Clin Med. 1981;97:739-749
3. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet. 1982;12:189-261, 453-454
4. Straat M, van Bruggen R, de Korte D, Juffermans NP. Red blood cell clearance in inflammation. Transfus Med Hemother. 2012;39:353-361
5. Thomsen JH, Etzerodt A, Svendsen P, Moestrup SK. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid Med Cell Longev. 2013;2013: 523652
6. Levy AP, Asleh R, Blum S, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal. 2010;12:293-304
7. Künzig HJ, Schmidt-Rohde P, Krämer M, Prinz H. Acute phase proteins (C-reactive protein, orosomucoid, haptoglobin)-specific markers in the diagnosis of inflammatory adnexal diseases [in German]. Geburtshilfe Frauenheilkd. 1985;45:881-886
8. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999;353:1649-1652
9. Ljung L, Olsson T, Engstrand S, Wållberg-Jonsson S, Söderberg S, Rantapää-Dahlqvist S. Interleukin-1 receptor antagonist is associated with both lipid metabolism and inflammation in rheumatoid arthritis. Clin Exp Rheumatol. 2007;25:617-620
10. Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:198-201
11. Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathwaysbasic science, clinical perspectives, and drug development. Front Physiol. 2014;5:415
12. Buehler PW, Vallelian F, MikolajczykMG, et al. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal. 2008;10:1449-1462
13. Lin T, Kwak YH, Sammy F, et al. Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis. 2010;202:624-632
14. Larsen R, Gozzelino R, Jeney V, et al.Acentral role for free heme in the pathogenesis of severe sepsis. Sci Transl Med. 2010;2:51ra71
15. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest. 1993;91:977-985
16. de Kleijn DP, SmeetsMB, Kemmeren PP, et al. Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J. 2002;16:1123-1125
17. Shen H, Song Y, Colangelo CM, et al. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest. 2012;122:383-387
18. Shen H, Heuzey E, Mori DN, et al. Haptoglobin enhances cardiac transplant rejection. Circ Res. 2015;116:1670-1679
19. Chiellini C, Bertacca A, Novelli SE, et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFβ. J Cell Physiol. 2002;190:251-258
20. Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953-966
21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112:1796-1808
22. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112: 1785-1788
23. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-1830
24. Kraakman MJ, Kammoun HL, Allen TL, et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metab. 2015;21:403-416
25. Donath MY. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov. 2014; 13:465-476
26. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54(suppl 2):S114-S124
27. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42:579-589
28. Friedrichs WE, Navarijo-Ashbaugh AL, Bowman BH, Yang F. Expression and inflammatory regulation of haptoglobin gene in adipocytes. Biochem Biophys Res Comm. 1995;209:250-256
29. Chiellini C, Santini F, Marsili A, et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab. 2004;89:2678-2683
30. Fain JN, Bahouth SW, Madan AK. Haptoglobin release by humanadipose tissue in primary culture. J Lipid Res. 2004; 45:536-542
31. Fain JN, Sacks HS, Bahouth SW, Tichansky DS, Madan AK, Cheema PS. Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat. Metabolism. 2010;59:1379-1386
32. Eisele I, Wood IS, German AJ, Hunter L, Trayhurn P. Adipokine gene expression in dog adipose tissues and dog white adipocytes differentiated in primary culture. Horm Metab Res. 2005;37:474-481
33. Saremi B, Al-Dawood A, Winand S, et al. Bovine haptoglobin as an adipokine: serum concentrations and tissue expression in dairy cows receiving a conjugated linoleic acids supplement throughout lactation. Vet Immunol Immunopathol. 2012;146:201-211
34. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem. 2001;276(36):34167-34174
35. Peinado JR, Pardo M, de la Rosa O, Malagón MM. Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity. Proteomics. 2012;12(4-5):607-620
36. do Nascimento CO, Hunter L, Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARα. Biochem Biophys Res Comm. 2004;313:702-708
37. Burton GR, Nagarajan R, Peterson CA, McGehee RE Jr. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene. 2004;329: 167-185
38. Castellot JJ Jr, Karnovsky MJ, Spiegelman BM. Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. Proc Natl Acad Sci USA. 1980; 77:6007-6011
39. Smas CM, Sul HS. Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1. Crit Rev Eukaryot Gene Expr. 1997;7:281-298
40. Kratchmarova I, Kalume DE, Blagoev B, et al.Aproteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes.Mol Cell Proteomics. 2002;1:213-222
41. Gamucci O, Lisi S, Scabia G, et al. Haptoglobin deficiency determines changes in adipocyte size and adipogenesis. Adipocyte. 2012;1:142-183
42. Shao X, Wang M, Wei X, et al. Peroxisome proliferatoractivated receptor-α: master regulator of adipogenesis and obesity. Curr Stem Cell Res Ther. 2016;11:282-289
43. Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding protein β promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 1994;8:1654-1663
44. Kong CS, Kim JA, Eom TK, Kim SK. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes. J Nutr Biochem. 2010;21:438-443
45. Herrera E, Amusquivar E. Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev. 2000;16:202-210
46. Lisi S, Gamucci O, Vottari T, et al. Obesity-associated hepatosteatosis and impairment of glucose homeostasis are attenuated by haptoglobin deficiency. Diabetes. 2011;60: 2496-2505
47. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006; 74:443-477
48. Lee MJ, Gong DW, Burkey BF, Fried SK. Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am J Physiol Endocrinol Metab. 2011;300:E571-E580
49. Tam CS, Heilbronn LK, Henegar C, et al. An early inflammatory gene profile in visceral adipose tissue in children. Int J Pediatr Obes. 2011;6:e360-e363
50. Goyal A, Nimmakayala KR, Zonszein J. Is there a paradox in obesity? Cardiol Rev. 2014;22:163-170
51. Siklova-Vitkova M, Klimcakova E, Polak J, et al. Adipose tissue secretion and expression of adipocyte-produced and stromavascular fraction-produced adipokines vary during multiple phases of weight-reducing dietary intervention in obese women. J Clin Endocrinol Metab. 2012;97:E1176-E1181
52. Pérez-Echarri N, Pérez-Matute P, Marcos-Gómez B, et al. Differential inflammatory status in rats susceptible or resistant to diet-induced obesity: effects of EPA ethyl ester treatment. Eur J Nutr. 2008;47:380-386
53. Oller do Nascimento CM, Ribeiro EB, Oyama LM. Metabolism and secretory function of white adipose tissue: effect of dietary fat. An Acad Bras Cienc. 2009;81:453-466
54. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA. 2000;97:11371-11376
55. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92:347-355
56. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005; 184:285-293
57. Castell JV, Gómez-Lechón MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 1988; 232:347-350
58. Baumann H, Morella KK, Wong GH. TNF-β, IL-1 , and hepatocyte growth factor cooperate in stimulating specific acute phase plasma protein genes in rat hepatoma cells. J Immunol. 1993;151:4248-4257
59. Sethi JK, Hotamisligil GS. The role of TNF β in adipocyte metabolism. Semin Cell Dev Biol. 1999;10:19-29
60. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60:349-356
61. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-β function. Nature. 1997;389:610-614
62. Samad F, Uysal KT, Wiesbrock SM, Pandey M, Hotamisligil GS, Loskutoff DJ. Tumor necrosis factor β is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci USA. 1999;96: 6902-6907
63. Wang B, Jenkins JR, Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-β. Am J Physiol Endocrinol Metab. 2005;288:E731-E740
64. Wang B, Trayhurn P. Acute and prolonged effects of TNF-β on the expression and secretion of inflammationrelated adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006;452:418-427
65. Andersson CX, Sopasakis VR, Wallerstedt E, Smith U. In-sulin antagonizes interleukin-6 signaling and is anti-inflammatory in 3T3-L1 adipocytes. J Biol Chem. 2007;282: 9430-9435
66. Poli V, Oliviero S, Morrone G, Cortese R. Characterization of an IL-6-responsive element (IL6RE) present on liverspecific genes and identification of the cognate IL-6-dependent DNA-binding protein (IL6DBP). Ann N Y Acad Sci. 1989;557:297-309
67. Bueno AA, Oyama LM, de Macedo Motoyama CS, et al. Long chain saturated fatty acids increase haptoglobin gene expression in C57BL/6J mice adipose tissue and 3T3-L1 cells. Eur J Nutr. 2010;49:235-241
68. Vernochet C, Davis KE, Scherer PE, Farmer SR. Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-α ligands in adipocytes. Endocrinology. 2010;151:586-594
69. Corzo C, Griffin PR. Targeting the peroxisome proliferator-activated receptor-α to counter the inflammatory milieu in obesity. Diabetes Metab J. 2013;37:395-403
70. Foryst-Ludwig A, Hartge M, Clemenz M, et al. PPARα activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovasc Diabetol. 2010;9:64
71. Vallianou NG, Evangelopoulos AA, Panagiotakos DB, et al. Associations of acute-phase reactants with metabolic syndrome in middle-aged overweight or obese people.Med Sci Monit. 2010;16:CR56-CR60
72. Doumatey AP, Lashley KS, Huang H, et al. Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans. Obesity. 2010;18: 598-603
73. Engström G, Hedblad B, Janzon L, Lindgärde F. Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study. Diabetologia. 2005;48:2525-2531
74. Pinheiro Volp AC, Santos Silva FC, Bressan J. Hepatic inflammatory biomarkers and its link with obesity and chronic diseases. Nutr Hosp. 2015;31:1947-1956
75. Taes YE, De Bacquer D, De Backer G, Delanghe JR. Haptoglobin and body mass index. J Clin Endocrinol Metab. 2005; 90:594; author reply 594-595
76. Ramalho R, Guimarães C, Gil C, Neves C, Guimarães JT, Delgado L. Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery. Obes Surg. 2009;19:915-920
77. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med. 2007;262:408-414
78. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-949
79. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147-152
80. Lazar MA. How obesity causes diabetes: not a tall tale. Science. 2005;307:373-375
81. Arkan MC, Hevener AL, Greten FR, et al. IKK- links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11:191-198
82. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006;116:115-124
83. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006; 116:1494-1505
84. Sell H, Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol. 2007;18: 258-262
85. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801
86. Ito A, Suganami T, Yamauchi A, et al. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem. 2008; 283:35715-35723
87. Inouye KE, Shi H, Howard JK, et al. Absence ofCCchemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes. 2007;56: 2242-2250
88. Godiska R, Chantry D, Raport CJ, Schweickart VL, Trong HL, Gray PW. Monocyte chemotactic protein-4: tissuespecific expression and signaling through CC chemokine receptor-2. J Leukoc Biol. 1997;61:353-360
89. Dzenko KA, Andjelkovic AV, Kuziel WA, Pachter JS. The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels. J Neurosci. 2001;21:9214-9223
90. Maffei M, Funicello M, Vottari T, et al. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2). BMC Biol. 2009;7:87
91. Garibay-Cerdenares OL, Hernández-Ramírez VI, Osorio-Trujillo JC, Gallardo-Rincón D, Talamás-Rohana P. Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment. Cell Adh Migr. 2015;9:394-405
92. Brodmerkel CM, Huber R, Covington M, et al. Discovery and pharmacological characterization of a novel rodentactive CCR2 antagonist, INCB3344. J Immunol. 2005; 175:5370-5378
93. Körmöczi GF, Säemann MD, Buchta C, et al. Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest. 2006;36:202-209
94. de Lemos JA, Morrow DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690-695
95. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond). 2005;29:146-150
96. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175-184
97. Lim SK, Kim H, Lim SK, et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood. 1998; 92:1870-1877
98. Ghigliotti G, Barisione C, Garibaldi S, et al. Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation. 2014;37: 1337-1353
99. Jo J, Gavrilova O, Pack S, et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol. 2009;5:e1000324
100. Lafontan M. Adipose tissue and adipocyte dysregulation. Diabetes Metab. 2014;40:16-28
101. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab. 2010;95:1544-1554
102. Larter CZ, Yeh MM, Van Rooyen DM, et al. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol. 2009;24:1658-1668
103. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112:91-100
104. Reid MB, Moylan JS. Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J Physiol. 2011;589:2171-2179
105. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech. 2013;6:25-39
106. Bertaggia E, Scabia G, Dalise S, et al. Haptoglobin is required to prevent oxidative stress and muscle atrophy. PLoS One. 2014;9:e100745
107. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006;17:1807-1819
108. Mizushima N, KomatsuM.Autophagy: renovation of cells and tissues. Cell. 2011;147:728-741
109. Curat CA, Miranville A, Sengenès C, et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes. 2004;53:1285-1292
110. Cortez-Pinto H, Machado M. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2008;2:217-231
111. Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15:8591-8638
112. Brenner DA. Reversibility of liver fibrosis. Gastroenterol Hepatol (NY). 2013;9:737-739
113. Sullivan T, Miao Z, Dairaghi DJ, et al. CCR2 antagonist CCX140-Bprovides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. Am J Physiol Renal Physiol. 2013;305:F1288-F1297
114. Aubert J, Dessolin S, Belmonte N, et al. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem. 1999;274:24965-24972
115. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 1964;239:375-380